成人T细胞白血病/淋巴瘤中CD28基因相关激活变异的临床意义
本研究纳入144例成人T细胞白血病/淋巴瘤(ATL)患者,检测CD28基因变异,发现10%存在基因融合、2%存在激活突变、24%存在拷贝数变异。携带CD28基因变异者更年轻,未接受异基因造血干细胞移植者预后倾向更差,慢性或冒烟型亚型中携带变异者预后显著更差。
要点
- ATL中CD28基因变异常见,包括融合(10%)、激活突变(2%)和拷贝数变异(24%)。
- 慢性或冒烟型ATL伴CD28基因变异者预后显著更差,对常规化疗或mogamulizumab更难治。
- 未接受异基因造血干细胞移植的CD28变异患者预后倾向更差。
核心结论
- ATL患者中CD28基因相关激活变异与更侵袭的临床病程相关,尤其在慢性或冒烟型亚型中预后显著更差。
研究设计与样本
- 研究纳入144例成人T细胞白血病/淋巴瘤患者,检测CD28基因变异并分析其临床意义。
主要发现
- 144例中,CD28基因融合14例(10%),CD28激活突变3例(2%),CD28拷贝数变异34例(24%)。
- 携带CD28基因变异的患者显著更年轻。
- 未接受异基因造血干细胞移植的患者中,携带CD28基因变异者预后倾向更差。
- 慢性或冒烟型ATL亚型中,携带CD28基因变异者预后显著更差。
临床怎么用
- 对ATL患者,尤其慢性或冒烟型亚型,可考虑检测CD28基因变异以识别预后更差、对常规化疗或mogamulizumab更难治的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple oncogenic events are involved in the development of adult T-cell leukaemia/lymphoma (ATL). Because CD28 plays a pivotal role in T-cell activation, we focused on alterations of the CD28 gene in ATL. We found multiple genetic abnormalities related to CD28 among the 144 patients enrolled in the present study. These involved gene fusions with the cytotoxic T-lymphocyte-associated antigen 4 or the inducible T-cell co-stimulator in 14 patients (10%), CD28-activating mutations in 3 (2%), and CD28 copy number variations in 34 (24%). Patients with such CD28 gene alterations were significantly younger than those without. In patients not receiving allogeneic haematopoietic stem cell transplantation, those with CD28 gene alterations tended to have a worse prognosis than those without. Finally, patients with chronic or smouldering ATL subtypes with CD28 gene alterations had a significantly worse prognosis than those without. These findings indicate that ATL, especially chronic or smouldering subtypes, have a more aggressive clinical course and are more refractory to conventional chemotherapies or mogamulizumab if they harbour CD28 gene alterations, likely because of continuous, prolonged, and enhanced CD28 activatory signalling. Novel treatment strategies to overcome the effects of these CD28 gene alterations are warranted.
引用
- Sakamoto Y, Ishida T, Masaki A, et al. Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphoma. Br J Haematol. 2020. PMID: 33205842. doi:10.1111/bjh.17211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。